NeuroPace

About:

NeuroPace develops and markets implantable devices for the treatment of neurological disorders.

Website: http://www.neuropace.com

Twitter/X: neuropace

Top Investors: OrbiMed, New Enterprise Associates, Angel Medical Systems, National Institutes of Health, Kleiner Perkins

Description:

NeuroPace designs develops, manufactures, and markets implantable devices for the treatment of neurological disorders. It offers a responsive Neurostimulator system (RNS) for the treatment of medically refractory partial epilepsy. The company's RNS system consists of implantable components, including RNS neurostimulator that delivers a short train of electrical pulses to the brain, and depth leads and cortical strip leads; and external products, such as the programmer, a laptop computer with proprietary software that has a wand and telemetry interface enabling communication with an implanted RNS neurostimulator. NeuroPace was incorporated in 1997 and is based in Mountain View, California.